[Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
Eight patients with WPW syndrome were catheterised and, during the course of this investigation, the electrophysiological effects of amiodarone were assessed. By  registering the potentials of the bundle of His and by using the stimulus-test technique, we were able to measure the refractory periods of the atrium and of the normal and accessory conducting pathways both before and during the first 40 minutes after an intra-atrial injection of 5 mg/kg of amiodarone chlorhydrate. The action of the conduction time was also studied. In the five cases in which we were able to measure it, the effective refractory period of the abnormal pathway increased, which led in two instances to the temporary suppression of all pre-excitation. At the same time, it was repeatedly found that the refractory periods of the A-V node were increased: the effective refractory period in 3/3 cases, and the functional refractory period in 2/2 cases. The effective refractory period of the right atrium was increased in 5 cases, and did not change in the others. The intranodal conduction time (A-H- interval) was always increased after amiodarone. Finally, in three patients runs of reciprocal tachycardia could be initiated by premature atrial stimulation. In one case, this was no longer possible after amiodarone. In the other two cases, although the attacks could still be brought on, they were slower because of the lengthening of the A-H interval. These findings explain why amiodarone is effective in controlling the tachycardia of WPW syndrome.
D000200:Action Potentials / Q000187:drug effects; D000328:Adult; D000638:Amiodarone / Q000494:pharmacology / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001572:Benzofurans / Q000627:therapeutic use*; D002036:Bundle of His / Q000187:drug effects; D002986:Clinical Trials as Topic; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D013610:Tachycardia / Q000188:drug therapy / Q000209:etiology; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D001572:Benzofurans; D000638:Amiodarone
Effets électrophysiologiques de l'amiodarone dans le syndrome de Wolff-Parkinson-White